Loading people...
Adam Gazzaley is the Founder and Executive Director of Neuroscape at UCSF, Co-founder of Akili Interactive, and Managing Partner at JAZZ Venture Partners, based in San Francisco, California. He bridges clinical neurology and digital medicine by developing experiential technologies, including EndeavorRx, the first FDA-cleared video game for treating ADHD created by Akili Interactive. The neurotechnology company transitioned to the public markets via a SPAC merger in 2022, while his venture capital firm, JAZZ Venture Partners, manages over $100 million in assets and recently raised a $75 million third fund in 2024. Gazzaley holds an MD and PhD from the Mount Sinai School of Medicine and completed his postdoctoral fellowship in cognitive neuroscience at UC Berkeley. He has authored more than 150 scientific papers and co-authored the bestselling book "The Distracted Mind." His career focuses on advancing digital therapeutics and cognitive training tools to enhance human brain health.
Adam Gazzaley is a distinguished Venture Partner at Jazz Venture Partners, a leading venture capital firm committed to investing in companies that leverage neuroscience and technology to enhance human health and performance. With a profound background as a neuroscientist and academic, Adam brings unparalleled scientific rigor and insight to the firm's investment strategy.
At Jazz Venture Partners, Adam plays a crucial role in identifying, evaluating, and supporting early-stage companies poised to revolutionize brain health, mental wellness, and human potential. His investment focus areas are deeply rooted in his expertise, encompassing digital therapeutics, neurotechnology, cognitive enhancement, personalized medicine, and solutions for improving mental and physical performance. He helps guide the firm's portfolio towards ventures that offer scientifically validated approaches to complex challenges in health and well-being.
Beyond his contributions to venture capital, Adam Gazzaley is a highly respected figure in academia. He is a Professor of Neurology, Physiology, and Psychiatry at the University of California, San Francisco (UCSF). Furthermore, he is the founder and Executive Director of Neuroscape, a translational neuroscience center at UCSF dedicated to developing and validating advanced technologies for brain assessment and optimization. His pioneering research explores how technology, including video games and virtual reality, can be harnessed to improve cognitive abilities, attention, and memory across the lifespan. He is also the co-author of "The Distracted Mind: Ancient Brains in a High-Tech World."
Adam's unique position at the nexus of cutting-edge neuroscience research and venture capital allows him to bridge the gap between scientific discovery and market-ready solutions. He provides invaluable guidance to Jazz Venture Partners' portfolio companies, ensuring their innovations are grounded in robust scientific principles and have the potential for significant real-world impact. While specific individual investments for a Venture Partner are often less publicized, his influence is evident across Jazz's portfolio, which includes companies developing digital treatments for neurological and psychiatric conditions, advanced brain training platforms, and tools for optimizing human performance. His vision is to empower individuals to achieve their full cognitive and emotional potential through scientifically informed technological advancements.
Adam Gazzaley is a renowned neuroscientist, Professor of Neurology, Physiology, and Psychiatry at UCSF, and a Venture Partner at Jazz Venture Partners. He is a pioneer in cognitive neuroscience and digital medicine.
Adam Gazzaley invests in companies at the forefront of neurotechnology, digital therapeutics, brain health, mental wellness, and human performance, leveraging his extensive expertise in neuroscience.
Adam Gazzaley works as a Venture Partner at Jazz Venture Partners. He is also a Professor at the University of California, San Francisco (UCSF), and the founder and Executive Director of Neuroscape.
